Omeros (OMER) Depreciation & Amortization (CF) (2010 - 2026)
Omeros recorded quarterly Depreciation & Amortization (CF) of $239000.0 in Q1 2026, up 1.7% quarter-over-quarter from $235000.0 in Q4 2025, and down 17.3% year-over-year from $289000.0 in Q1 2025.
Omeros' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $239000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 17.3% year-over-year to $239000.0; the TTM figure through Mar 2026 stood at $914000.0 (down 11.69% YoY), while the FY2025 annual figure was $964000.0, up 1.47% from the prior year.
- Depreciation & Amortization (CF) came in at $239000.0 for Q1 2026 at Omeros, up from $235000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $301000.0 in Q4 2024 to a low of $163000.0 in Q4 2022.
- A 5-year average of $235529.4 and a median of $235000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) tumbled 50.0% in 2022 and surged 50.0% in 2023, its largest moves.
- Omeros' Depreciation & Amortization (CF) stood at $163000.0 in 2022, then rose by 25.77% to $205000.0 in 2023, then soared by 46.83% to $301000.0 in 2024, then decreased by 21.93% to $235000.0 in 2025, then grew by 1.7% to $239000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $239000.0, $235000.0, and $240000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 239,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 239,000.00 |
| Mar 31, 2026 | 239,000.00 |
| Dec 31, 2025 | 235,000.00 |
| Dec 31, 2025 | 235,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Sep 30, 2025 | 240,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Mar 31, 2025 | 289,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Dec 31, 2024 | 301,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 208,000.00 |
| Mar 31, 2024 | 204,000.00 |
| Mar 31, 2024 | 204,000.00 |
| Dec 31, 2023 | 205,000.00 |
| Dec 31, 2023 | 205,000.00 |
| Sep 30, 2023 | 197,000.00 |
| Sep 30, 2023 | 197,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 186,000.00 |
| Mar 31, 2023 | 186,000.00 |
| Dec 31, 2022 | 163,000.00 |
| Dec 31, 2022 | 163,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 324,000.00 |
| Dec 31, 2021 | 324,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 400,000.00 |
| Mar 31, 2021 | 390,000.00 |
| Mar 31, 2021 | 390,000.00 |
| Dec 31, 2020 | 400,000.00 |
| Dec 31, 2020 | 400,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 400,000.00 |
| Mar 31, 2020 | 402,000.00 |
| Mar 31, 2020 | 402,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Dec 31, 2019 | 500,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 423,000.00 |
| Jun 30, 2019 | 423,000.00 |
| Mar 31, 2019 | 377,000.00 |
| Mar 31, 2019 | 377,000.00 |
| Dec 31, 2018 | 262,000.00 |
| Dec 31, 2018 | 262,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Sep 30, 2018 | 300,000.00 |
| Jun 30, 2018 | 177,000.00 |
| Jun 30, 2018 | 177,000.00 |
| Mar 31, 2018 | 223,000.00 |
| Mar 31, 2018 | 223,000.00 |
| Dec 31, 2017 | 222,000.00 |
| Dec 31, 2017 | 222,000.00 |
| Sep 30, 2017 | 144,000.00 |
| Sep 30, 2017 | 144,000.00 |
| Jun 30, 2017 | 119,000.00 |
| Jun 30, 2017 | 119,000.00 |
| Mar 31, 2017 | 115,000.00 |
| Mar 31, 2017 | 115,000.00 |
| Dec 31, 2016 | 89,000.00 |
| Dec 31, 2016 | 89,000.00 |
| Sep 30, 2016 | 89,000.00 |
| Sep 30, 2016 | 89,000.00 |
| Jun 30, 2016 | 69,000.00 |
| Jun 30, 2016 | 69,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Dec 31, 2015 | 48,000.00 |
| Dec 31, 2015 | 48,000.00 |
| Sep 30, 2015 | 54,000.00 |
| Sep 30, 2015 | 54,000.00 |
| Jun 30, 2015 | 52,000.00 |
| Jun 30, 2015 | 52,000.00 |
| Mar 31, 2015 | 55,000.00 |
| Mar 31, 2015 | 55,000.00 |
| Dec 31, 2014 | 71,000.00 |
| Dec 31, 2014 | 71,000.00 |
| Sep 30, 2014 | 82,000.00 |
| Sep 30, 2014 | 82,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Jun 30, 2014 | 82,000.00 |
| Mar 31, 2014 | 82,000.00 |
| Mar 31, 2014 | 82,000.00 |
| Dec 31, 2013 | 80,000.00 |
| Dec 31, 2013 | 80,000.00 |
| Sep 30, 2013 | 77,000.00 |
| Sep 30, 2013 | 77,000.00 |
| Jun 30, 2013 | 78,000.00 |
| Jun 30, 2013 | 78,000.00 |
| Mar 31, 2013 | 67,000.00 |
| Mar 31, 2013 | 67,000.00 |
| Dec 31, 2012 | 88,000.00 |
| Dec 31, 2012 | 88,000.00 |
| Sep 30, 2012 | 67,000.00 |
| Sep 30, 2012 | 67,000.00 |
| Jun 30, 2012 | 72,000.00 |
| Jun 30, 2012 | 72,000.00 |
| Mar 31, 2012 | 93,000.00 |
| Mar 31, 2012 | 93,000.00 |
| Dec 31, 2011 | 99,000.00 |
| Dec 31, 2011 | 99,000.00 |
| Sep 30, 2011 | 109,000.00 |
| Sep 30, 2011 | 109,000.00 |
| Jun 30, 2011 | 59,000.00 |
| Jun 30, 2011 | 59,000.00 |
| Mar 31, 2011 | 168,000.00 |
| Mar 31, 2011 | 168,000.00 |
| Dec 31, 2010 | 64,000.00 |
| Dec 31, 2010 | 64,000.00 |
| Sep 30, 2010 | 147,000.00 |
| Sep 30, 2010 | 147,000.00 |